Global Cancer Stem Cell Market Size, Status and Forecast 2023-2027

Report ID: 1013408 | Published Date: Jan 2025 | No. of Page: 106 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Cancer Stem Cell Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Cell Culturing
        1.2.3 Cell Separation
        1.2.4 Cell Analysis
        1.2.5 Molecular Analysis
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Cancer Stem Cell Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Stem Cell Based Cancer Therapy
        1.3.3 Targeted CSCs
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Cancer Stem Cell Market Perspective (2016-2027)
    2.2 Cancer Stem Cell Growth Trends by Regions
        2.2.1 Cancer Stem Cell Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Cancer Stem Cell Historic Market Share by Regions (2016-2021)
        2.2.3 Cancer Stem Cell Forecasted Market Size by Regions (2022-2027)
    2.3 Cancer Stem Cell Industry Dynamic
        2.3.1 Cancer Stem Cell Market Trends
        2.3.2 Cancer Stem Cell Market Drivers
        2.3.3 Cancer Stem Cell Market Challenges
        2.3.4 Cancer Stem Cell Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Cancer Stem Cell Players by Revenue
        3.1.1 Global Top Cancer Stem Cell Players by Revenue (2016-2021)
        3.1.2 Global Cancer Stem Cell Revenue Market Share by Players (2016-2021)
    3.2 Global Cancer Stem Cell Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Cancer Stem Cell Revenue
    3.4 Global Cancer Stem Cell Market Concentration Ratio
        3.4.1 Global Cancer Stem Cell Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Cancer Stem Cell Revenue in 2020
    3.5 Cancer Stem Cell Key Players Head office and Area Served
    3.6 Key Players Cancer Stem Cell Product Solution and Service
    3.7 Date of Enter into Cancer Stem Cell Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Stem Cell Breakdown Data by Type
    4.1 Global Cancer Stem Cell Historic Market Size by Type (2016-2021)
    4.2 Global Cancer Stem Cell Forecasted Market Size by Type (2022-2027)

5 Cancer Stem Cell Breakdown Data by Application
    5.1 Global Cancer Stem Cell Historic Market Size by Application (2016-2021)
    5.2 Global Cancer Stem Cell Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Cancer Stem Cell Market Size (2016-2027)
    6.2 North America Cancer Stem Cell Market Size by Type
        6.2.1 North America Cancer Stem Cell Market Size by Type (2016-2021)
        6.2.2 North America Cancer Stem Cell Market Size by Type (2022-2027)
        6.2.3 North America Cancer Stem Cell Market Size by Type (2016-2027)
    6.3 North America Cancer Stem Cell Market Size by Application
        6.3.1 North America Cancer Stem Cell Market Size by Application (2016-2021)
        6.3.2 North America Cancer Stem Cell Market Size by Application (2022-2027)
        6.3.3 North America Cancer Stem Cell Market Size by Application (2016-2027)
    6.4 North America Cancer Stem Cell Market Size by Country
        6.4.1 North America Cancer Stem Cell Market Size by Country (2016-2021)
        6.4.2 North America Cancer Stem Cell Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Cancer Stem Cell Market Size (2016-2027)
    7.2 Europe Cancer Stem Cell Market Size by Type
        7.2.1 Europe Cancer Stem Cell Market Size by Type (2016-2021)
        7.2.2 Europe Cancer Stem Cell Market Size by Type (2022-2027)
        7.2.3 Europe Cancer Stem Cell Market Size by Type (2016-2027)
    7.3 Europe Cancer Stem Cell Market Size by Application
        7.3.1 Europe Cancer Stem Cell Market Size by Application (2016-2021)
        7.3.2 Europe Cancer Stem Cell Market Size by Application (2022-2027)
        7.3.3 Europe Cancer Stem Cell Market Size by Application (2016-2027)
    7.4 Europe Cancer Stem Cell Market Size by Country
        7.4.1 Europe Cancer Stem Cell Market Size by Country (2016-2021)
        7.4.2 Europe Cancer Stem Cell Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Cancer Stem Cell Market Size (2016-2027)
    8.2 Asia-Pacific Cancer Stem Cell Market Size by Type
        8.2.1 Asia-Pacific Cancer Stem Cell Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Cancer Stem Cell Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Cancer Stem Cell Market Size by Type (2016-2027)
    8.3 Asia-Pacific Cancer Stem Cell Market Size by Application
        8.3.1 Asia-Pacific Cancer Stem Cell Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Cancer Stem Cell Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Cancer Stem Cell Market Size by Application (2016-2027)
    8.4 Asia-Pacific Cancer Stem Cell Market Size by Region
        8.4.1 Asia-Pacific Cancer Stem Cell Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Cancer Stem Cell Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Cancer Stem Cell Market Size (2016-2027)
    9.2 Latin America Cancer Stem Cell Market Size by Type
        9.2.1 Latin America Cancer Stem Cell Market Size by Type (2016-2021)
        9.2.2 Latin America Cancer Stem Cell Market Size by Type (2022-2027)
        9.2.3 Latin America Cancer Stem Cell Market Size by Type (2016-2027)
    9.3 Latin America Cancer Stem Cell Market Size by Application
        9.3.1 Latin America Cancer Stem Cell Market Size by Application (2016-2021)
        9.3.2 Latin America Cancer Stem Cell Market Size by Application (2022-2027)
        9.3.3 Latin America Cancer Stem Cell Market Size by Application (2016-2027)
    9.4 Latin America Cancer Stem Cell Market Size by Country
        9.4.1 Latin America Cancer Stem Cell Market Size by Country (2016-2021)
        9.4.2 Latin America Cancer Stem Cell Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Cancer Stem Cell Market Size (2016-2027)
    10.2 Middle East & Africa Cancer Stem Cell Market Size by Type
        10.2.1 Middle East & Africa Cancer Stem Cell Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Cancer Stem Cell Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Cancer Stem Cell Market Size by Type (2016-2027)
    10.3 Middle East & Africa Cancer Stem Cell Market Size by Application
        10.3.1 Middle East & Africa Cancer Stem Cell Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Cancer Stem Cell Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Cancer Stem Cell Market Size by Application (2016-2027)
    10.4 Middle East & Africa Cancer Stem Cell Market Size by Country
        10.4.1 Middle East & Africa Cancer Stem Cell Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Cancer Stem Cell Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Thermo Fisher Scientific, Inc.
        11.1.1 Thermo Fisher Scientific, Inc. Company Details
        11.1.2 Thermo Fisher Scientific, Inc. Business Overview
        11.1.3 Thermo Fisher Scientific, Inc. Cancer Stem Cell Introduction
        11.1.4 Thermo Fisher Scientific, Inc. Revenue in Cancer Stem Cell Business (2016-2021)
        11.1.5 Thermo Fisher Scientific, Inc. Recent Development
    11.2 AbbVie, Inc.
        11.2.1 AbbVie, Inc. Company Details
        11.2.2 AbbVie, Inc. Business Overview
        11.2.3 AbbVie, Inc. Cancer Stem Cell Introduction
        11.2.4 AbbVie, Inc. Revenue in Cancer Stem Cell Business (2016-2021)
        11.2.5 AbbVie, Inc. Recent Development
    11.3 Merck KGaA
        11.3.1 Merck KGaA Company Details
        11.3.2 Merck KGaA Business Overview
        11.3.3 Merck KGaA Cancer Stem Cell Introduction
        11.3.4 Merck KGaA Revenue in Cancer Stem Cell Business (2016-2021)
        11.3.5 Merck KGaA Recent Development
    11.4 Bionomics
        11.4.1 Bionomics Company Details
        11.4.2 Bionomics Business Overview
        11.4.3 Bionomics Cancer Stem Cell Introduction
        11.4.4 Bionomics Revenue in Cancer Stem Cell Business (2016-2021)
        11.4.5 Bionomics Recent Development
    11.5 Lonza
        11.5.1 Lonza Company Details
        11.5.2 Lonza Business Overview
        11.5.3 Lonza Cancer Stem Cell Introduction
        11.5.4 Lonza Revenue in Cancer Stem Cell Business (2016-2021)
        11.5.5 Lonza Recent Development
    11.6 Stemline Therapeutics, Inc.
        11.6.1 Stemline Therapeutics, Inc. Company Details
        11.6.2 Stemline Therapeutics, Inc. Business Overview
        11.6.3 Stemline Therapeutics, Inc. Cancer Stem Cell Introduction
        11.6.4 Stemline Therapeutics, Inc. Revenue in Cancer Stem Cell Business (2016-2021)
        11.6.5 Stemline Therapeutics, Inc. Recent Development
    11.7 Miltenyi Biotec
        11.7.1 Miltenyi Biotec Company Details
        11.7.2 Miltenyi Biotec Business Overview
        11.7.3 Miltenyi Biotec Cancer Stem Cell Introduction
        11.7.4 Miltenyi Biotec Revenue in Cancer Stem Cell Business (2016-2021)
        11.7.5 Miltenyi Biotec Recent Development
    11.8 PromoCell GmbH
        11.8.1 PromoCell GmbH Company Details
        11.8.2 PromoCell GmbH Business Overview
        11.8.3 PromoCell GmbH Cancer Stem Cell Introduction
        11.8.4 PromoCell GmbH Revenue in Cancer Stem Cell Business (2016-2021)
        11.8.5 PromoCell GmbH Recent Development
    11.9 MacroGenics, Inc.
        11.9.1 MacroGenics, Inc. Company Details
        11.9.2 MacroGenics, Inc. Business Overview
        11.9.3 MacroGenics, Inc. Cancer Stem Cell Introduction
        11.9.4 MacroGenics, Inc. Revenue in Cancer Stem Cell Business (2016-2021)
        11.9.5 MacroGenics, Inc. Recent Development
    11.10 OncoMed Pharmaceuticals, Inc.
        11.10.1 OncoMed Pharmaceuticals, Inc. Company Details
        11.10.2 OncoMed Pharmaceuticals, Inc. Business Overview
        11.10.3 OncoMed Pharmaceuticals, Inc. Cancer Stem Cell Introduction
        11.10.4 OncoMed Pharmaceuticals, Inc. Revenue in Cancer Stem Cell Business (2016-2021)
        11.10.5 OncoMed Pharmaceuticals, Inc. Recent Development
    11.11 Irvine Scientific
        11.11.1 Irvine Scientific Company Details
        11.11.2 Irvine Scientific Business Overview
        11.11.3 Irvine Scientific Cancer Stem Cell Introduction
        11.11.4 Irvine Scientific Revenue in Cancer Stem Cell Business (2016-2021)
        11.11.5 Irvine Scientific Recent Development
    11.12 STEMCELL Technologies Inc.
        11.12.1 STEMCELL Technologies Inc. Company Details
        11.12.2 STEMCELL Technologies Inc. Business Overview
        11.12.3 STEMCELL Technologies Inc. Cancer Stem Cell Introduction
        11.12.4 STEMCELL Technologies Inc. Revenue in Cancer Stem Cell Business (2016-2021)
        11.12.5 STEMCELL Technologies Inc. Recent Development
    11.13 Sino Biological Inc.
        11.13.1 Sino Biological Inc. Company Details
        11.13.2 Sino Biological Inc. Business Overview
        11.13.3 Sino Biological Inc. Cancer Stem Cell Introduction
        11.13.4 Sino Biological Inc. Revenue in Cancer Stem Cell Business (2016-2021)
        11.13.5 Sino Biological Inc. Recent Development
    11.14 BIOTIME, Inc.
        11.14.1 BIOTIME, Inc. Company Details
        11.14.2 BIOTIME, Inc. Business Overview
        11.14.3 BIOTIME, Inc. Cancer Stem Cell Introduction
        11.14.4 BIOTIME, Inc. Revenue in Cancer Stem Cell Business (2016-2021)
        11.14.5 BIOTIME, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Cancer Stem Cell Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Cell Culturing
    Table 3. Key Players of Cell Separation
    Table 4. Key Players of Cell Analysis
    Table 5. Key Players of Molecular Analysis
    Table 6. Key Players of Others
    Table 7. Global Cancer Stem Cell Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Cancer Stem Cell Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Cancer Stem Cell Market Size by Regions (2016-2021) & (US$ Million)
    Table 10. Global Cancer Stem Cell Market Share by Regions (2016-2021)
    Table 11. Global Cancer Stem Cell Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 12. Global Cancer Stem Cell Market Share by Regions (2022-2027)
    Table 13. Cancer Stem Cell Market Trends
    Table 14. Cancer Stem Cell Market Drivers
    Table 15. Cancer Stem Cell Market Challenges
    Table 16. Cancer Stem Cell Market Restraints
    Table 17. Global Cancer Stem Cell Revenue by Players (2016-2021) & (US$ Million)
    Table 18. Global Cancer Stem Cell Market Share by Players (2016-2021)
    Table 19. Global Top Cancer Stem Cell Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Stem Cell as of 2020)
    Table 20. Ranking of Global Top Cancer Stem Cell Companies by Revenue (US$ Million) in 2020
    Table 21. Global 5 Largest Players Market Share by Cancer Stem Cell Revenue (CR5 and HHI) & (2016-2021)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Cancer Stem Cell Product Solution and Service
    Table 24. Date of Enter into Cancer Stem Cell Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Cancer Stem Cell Market Size by Type (2016-2021) (US$ Million)
    Table 27. Global Cancer Stem Cell Revenue Market Share by Type (2016-2021)
    Table 28. Global Cancer Stem Cell Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 29. Global Cancer Stem Cell Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 30. Global Cancer Stem Cell Market Size Share by Application (2016-2021) & (US$ Million)
    Table 31. Global Cancer Stem Cell Revenue Market Share by Application (2016-2021)
    Table 32. Global Cancer Stem Cell Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 33. Global Cancer Stem Cell Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 34. North America Cancer Stem Cell Market Size by Type (2016-2021) (US$ Million)
    Table 35. North America Cancer Stem Cell Market Size by Type (2022-2027) & (US$ Million)
    Table 36. North America Cancer Stem Cell Market Size by Application (2016-2021) (US$ Million)
    Table 37. North America Cancer Stem Cell Market Size by Application (2022-2027) & (US$ Million)
    Table 38. North America Cancer Stem Cell Market Size by Country (2016-2021) & (US$ Million) 
    Table 39. North America Cancer Stem Cell Market Size by Country (2022-2027) & (US$ Million) 
    Table 40. Europe Cancer Stem Cell Market Size by Type (2016-2021) (US$ Million)
    Table 41. Europe Cancer Stem Cell Market Size by Type (2022-2027) & (US$ Million)
    Table 42. Europe Cancer Stem Cell Market Size by Application (2016-2021) (US$ Million)
    Table 43. Europe Cancer Stem Cell Market Size by Application (2022-2027) & (US$ Million)
    Table 44. Europe Cancer Stem Cell Market Size by Country (2016-2021) & (US$ Million) 
    Table 45. Europe Cancer Stem Cell Market Size by Country (2022-2027) & (US$ Million) 
    Table 46. Asia-Pacific Cancer Stem Cell Market Size by Type (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Cancer Stem Cell Market Size by Type (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Cancer Stem Cell Market Size by Application (2016-2021) (US$ Million)
    Table 49. Asia-Pacific Cancer Stem Cell Market Size by Application (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific Cancer Stem Cell Market Size by Region (2016-2021) & (US$ Million) 
    Table 51. Asia-Pacific Cancer Stem Cell Market Size by Region (2022-2027) & (US$ Million) 
    Table 52. Latin America Cancer Stem Cell Market Size by Type (2016-2021) (US$ Million)
    Table 53. Latin America Cancer Stem Cell Market Size by Type (2022-2027) & (US$ Million)
    Table 54. Latin America Cancer Stem Cell Market Size by Application (2016-2021) (US$ Million)
    Table 55. Latin America Cancer Stem Cell Market Size by Application (2022-2027) & (US$ Million)
    Table 56. Latin America Cancer Stem Cell Market Size by Country (2016-2021) & (US$ Million) 
    Table 57. Latin America Cancer Stem Cell Market Size by Country (2022-2027) & (US$ Million) 
    Table 58. Middle East & Africa Cancer Stem Cell Market Size by Type (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Cancer Stem Cell Market Size by Type (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Cancer Stem Cell Market Size by Application (2016-2021) (US$ Million)
    Table 61. Middle East & Africa Cancer Stem Cell Market Size by Application (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa Cancer Stem Cell Market Size by Country (2016-2021) & (US$ Million) 
    Table 63. Middle East & Africa Cancer Stem Cell Market Size by Country (2022-2027) & (US$ Million) 
    Table 64. Thermo Fisher Scientific, Inc. Company Details
    Table 65. Thermo Fisher Scientific, Inc. Business Overview
    Table 66. Thermo Fisher Scientific, Inc. Cancer Stem Cell Product
    Table 67. Thermo Fisher Scientific, Inc. Revenue in Cancer Stem Cell Business (2016-2021) & (US$ Million)
    Table 68. Thermo Fisher Scientific, Inc. Recent Development
    Table 69. AbbVie, Inc. Company Details
    Table 70. AbbVie, Inc. Business Overview
    Table 71. AbbVie, Inc. Cancer Stem Cell Product
    Table 72. AbbVie, Inc. Revenue in Cancer Stem Cell Business (2016-2021) & (US$ Million)
    Table 73. AbbVie, Inc. Recent Development
    Table 74. Merck KGaA Company Details
    Table 75. Merck KGaA Business Overview
    Table 76. Merck KGaA Cancer Stem Cell Product
    Table 77. Merck KGaA Revenue in Cancer Stem Cell Business (2016-2021) & (US$ Million)
    Table 78. Merck KGaA Recent Development
    Table 79. Bionomics Company Details
    Table 80. Bionomics Business Overview
    Table 81. Bionomics Cancer Stem Cell Product
    Table 82. Bionomics Revenue in Cancer Stem Cell Business (2016-2021) & (US$ Million)
    Table 83. Bionomics Recent Development
    Table 84. Lonza Company Details
    Table 85. Lonza Business Overview
    Table 86. Lonza Cancer Stem Cell Product
    Table 87. Lonza Revenue in Cancer Stem Cell Business (2016-2021) & (US$ Million)
    Table 88. Lonza Recent Development
    Table 89. Stemline Therapeutics, Inc. Company Details
    Table 90. Stemline Therapeutics, Inc. Business Overview
    Table 91. Stemline Therapeutics, Inc. Cancer Stem Cell Product
    Table 92. Stemline Therapeutics, Inc. Revenue in Cancer Stem Cell Business (2016-2021) & (US$ Million)
    Table 93. Stemline Therapeutics, Inc. Recent Development
    Table 94. Miltenyi Biotec Company Details
    Table 95. Miltenyi Biotec Business Overview
    Table 96. Miltenyi Biotec Cancer Stem Cell Product
    Table 97. Miltenyi Biotec Revenue in Cancer Stem Cell Business (2016-2021) & (US$ Million)
    Table 98. Miltenyi Biotec Recent Development
    Table 99. PromoCell GmbH Company Details
    Table 100. PromoCell GmbH Business Overview
    Table 101. PromoCell GmbH Revenue in Cancer Stem Cell Business (2016-2021) & (US$ Million)
    Table 102. PromoCell GmbH Recent Development
    Table 103. MacroGenics, Inc. Company Details
    Table 104. MacroGenics, Inc. Business Overview
    Table 105. MacroGenics, Inc. Cancer Stem Cell Product
    Table 106. MacroGenics, Inc. Revenue in Cancer Stem Cell Business (2016-2021) & (US$ Million)
    Table 107. MacroGenics, Inc. Recent Development
    Table 108. OncoMed Pharmaceuticals, Inc. Company Details
    Table 109. OncoMed Pharmaceuticals, Inc. Business Overview
    Table 110. OncoMed Pharmaceuticals, Inc. Cancer Stem Cell Product
    Table 111. OncoMed Pharmaceuticals, Inc. Revenue in Cancer Stem Cell Business (2016-2021) & (US$ Million)
    Table 112. OncoMed Pharmaceuticals, Inc. Recent Development
    Table 113. Irvine Scientific Company Details
    Table 114. Irvine Scientific Business Overview
    Table 115. Irvine Scientific Cancer Stem Cell Product
    Table 116. Irvine Scientific Revenue in Cancer Stem Cell Business (2016-2021) & (US$ Million)
    Table 117. Irvine Scientific Recent Development
    Table 118. STEMCELL Technologies Inc. Company Details
    Table 119. STEMCELL Technologies Inc. Business Overview
    Table 120. STEMCELL Technologies Inc. Cancer Stem Cell Product
    Table 121. STEMCELL Technologies Inc. Revenue in Cancer Stem Cell Business (2016-2021) & (US$ Million)
    Table 122. STEMCELL Technologies Inc. Recent Development
    Table 123. Sino Biological Inc. Company Details
    Table 124. Sino Biological Inc. Business Overview
    Table 125. Sino Biological Inc. Cancer Stem Cell Product
    Table 126. Sino Biological Inc. Revenue in Cancer Stem Cell Business (2016-2021) & (US$ Million)
    Table 127. Sino Biological Inc. Recent Development
    Table 128. BIOTIME, Inc. Company Details
    Table 129. BIOTIME, Inc. Business Overview
    Table 130. BIOTIME, Inc. Cancer Stem Cell Product
    Table 131. BIOTIME, Inc. Revenue in Cancer Stem Cell Business (2016-2021) & (US$ Million)
    Table 132. BIOTIME, Inc. Recent Development
    Table 133. Research Programs/Design for This Report
    Table 134. Key Data Information from Secondary Sources
    Table 135. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cancer Stem Cell Market Share by Type: 2020 VS 2027
    Figure 2. Cell Culturing Features
    Figure 3. Cell Separation Features
    Figure 4. Cell Analysis Features
    Figure 5. Molecular Analysis Features
    Figure 6. Others Features
    Figure 7. Global Cancer Stem Cell Market Share by Application: 2020 VS 2027
    Figure 8. Stem Cell Based Cancer Therapy Case Studies
    Figure 9. Targeted CSCs Case Studies
    Figure 10. Cancer Stem Cell Report Years Considered
    Figure 11. Global Cancer Stem Cell Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 12. Global Cancer Stem Cell Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Cancer Stem Cell Market Share by Regions: 2020 VS 2027
    Figure 14. Global Cancer Stem Cell Market Share by Regions (2022-2027)
    Figure 15. Global Cancer Stem Cell Market Share by Players in 2020
    Figure 16. Global Top Cancer Stem Cell Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Stem Cell as of 2020
    Figure 17. The Top 10 and 5 Players Market Share by Cancer Stem Cell Revenue in 2020
    Figure 18. Global Cancer Stem Cell Revenue Market Share by Type (2016-2021)
    Figure 19. Global Cancer Stem Cell Revenue Market Share by Type (2022-2027)
    Figure 20. North America Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 21. North America Cancer Stem Cell Market Share by Type (2016-2027)
    Figure 22. North America Cancer Stem Cell Market Share by Application (2016-2027)
    Figure 23. North America Cancer Stem Cell Market Share by Country (2016-2027)
    Figure 24. United States Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Canada Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Cancer Stem Cell Market Share by Type (2016-2027)
    Figure 28. Europe Cancer Stem Cell Market Share by Application (2016-2027)
    Figure 29. Europe Cancer Stem Cell Market Share by Country (2016-2027)
    Figure 30. Germany Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. France Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. U.K. Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Italy Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Russia Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Nordic Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Cancer Stem Cell Market Share by Type (2016-2027)
    Figure 38. Asia-Pacific Cancer Stem Cell Market Share by Application (2016-2027)
    Figure 39. Asia-Pacific Cancer Stem Cell Market Share by Region (2016-2027)
    Figure 40. China Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Japan Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. South Korea Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Southeast Asia Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. India Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Australia Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Cancer Stem Cell Market Share by Type (2016-2027)
    Figure 48. Latin America Cancer Stem Cell Market Share by Application (2016-2027)
    Figure 49. Latin America Cancer Stem Cell Market Share by Country (2016-2027)
    Figure 50. Mexico Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Brazil Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Cancer Stem Cell Market Share by Type (2016-2027)
    Figure 54. Middle East & Africa Cancer Stem Cell Market Share by Application (2016-2027)
    Figure 55. Middle East & Africa Cancer Stem Cell Market Share by Country (2016-2027)
    Figure 56. Turkey Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Saudi Arabia Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. UAE Cancer Stem Cell Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Cancer Stem Cell Business (2016-2021)
    Figure 60. AbbVie, Inc. Revenue Growth Rate in Cancer Stem Cell Business (2016-2021)
    Figure 61. Merck KGaA Revenue Growth Rate in Cancer Stem Cell Business (2016-2021)
    Figure 62. Bionomics Revenue Growth Rate in Cancer Stem Cell Business (2016-2021)
    Figure 63. Lonza Revenue Growth Rate in Cancer Stem Cell Business (2016-2021)
    Figure 64. Stemline Therapeutics, Inc. Revenue Growth Rate in Cancer Stem Cell Business (2016-2021)
    Figure 65. Miltenyi Biotec Revenue Growth Rate in Cancer Stem Cell Business (2016-2021)
    Figure 66. PromoCell GmbH Revenue Growth Rate in Cancer Stem Cell Business (2016-2021)
    Figure 67. MacroGenics, Inc. Revenue Growth Rate in Cancer Stem Cell Business (2016-2021)
    Figure 68. OncoMed Pharmaceuticals, Inc. Revenue Growth Rate in Cancer Stem Cell Business (2016-2021)
    Figure 69. Irvine Scientific Revenue Growth Rate in Cancer Stem Cell Business (2016-2021)
    Figure 70. STEMCELL Technologies Inc. Revenue Growth Rate in Cancer Stem Cell Business (2016-2021)
    Figure 71. Sino Biological Inc. Revenue Growth Rate in Cancer Stem Cell Business (2016-2021)
    Figure 72. BIOTIME, Inc. Revenue Growth Rate in Cancer Stem Cell Business (2016-2021)
    Figure 73. Bottom-up and Top-down Approaches for This Report
    Figure 74. Data Triangulation
    Figure 75. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Thermo Fisher Scientific, Inc.
AbbVie, Inc.
Merck KGaA
Bionomics
Lonza
Stemline Therapeutics, Inc.
Miltenyi Biotec
PromoCell GmbH
MacroGenics, Inc.
OncoMed Pharmaceuticals, Inc.
Irvine Scientific
STEMCELL Technologies Inc.
Sino Biological Inc.
BIOTIME, Inc.
Frequently Asked Questions
Cancer Stem Cell report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cancer Stem Cell report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cancer Stem Cell report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Cancer Therapies

Cancer therapy describes the treatment of cancer in a patient, often with surgery, chemotherapy a ... Read More

Casinos

Casinos are establishments where people can participate in various forms of gambling, and the cas ... Read More